Practical issues and strategies of biological product technology transfer
In this webinar, we will introduce the practical issues and strategies of biological product technology transfer. We focus on the concept and work flow of tech transfer, and conclude some key points to complete a successful transfer. Furthermore, some case studies were took as examples to make the understanding of tech transfer easily.
Aipeng Deng
Senior Scientist of MAST, ProBio
Aipeng Deng graduated from Nanjing University of science and technology, and obtained his PHD degree in biochemistry. He is in charge of manufacturing science and technology (MSAT) after joined Genscript in 2019.
He has experience in both process development and manufacturing, and has led kinds of tech transfer projects successfully.
Related Service
ProBio now owns 5 independent GMP production lines with a total culture volume of 2,600L; and 3 independent downstream purification lines; the annual production capacity can reach up to 104 batches per year. We can ensure completion of tech-transfer process in only 2 months to quickly start GMP manufacturing. The manufacturing center functions based on the quality system of highest standard and meets the GMP requirements of NMPA, FDA, EMA, etc.